Global diabetes drug market expected to rise 3.6 percent
A new report predicts that the global diabetes drug market will rise to US$58.4 billion by 2025.
List view / Grid view
A new report predicts that the global diabetes drug market will rise to US$58.4 billion by 2025.
NICE has released a Final Appraisal Document recommending Nexavar for the treatment of patients with advanced hepatocellular carcinoma...
Bayer have announced the European Commission has granted marketing authorisation for Stivarga...
Major market players across the US are upping investments in research to innovate on treatment methods and improve ophthalmic drugs action...